Smith Borakaeyabe Babiaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Smith Borakaeyabe Babiaka has a total of 219 co-authors. Here are the top co-authors by number of shared publications:
- Conrad Veranso Simoben
Structural Genomics Consortium University of Toronto Toronto Ontario Canada
9 shared publications - Fidele Ntie-Kang
University of Buea
7 shared publications - Kennedy Omondi Abuga
Department of Pharmaceutical Chemistry, Pharmaceutics & Pharmacognosy, Faculty of Health Sciences, University of Nairobi, P.O. Box 19676-00202, Nairobi, Kenya
5 shared publications - Aurélien F. A. Moumbock
Institute of Pharmaceutical Sciences, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany
4 shared publications - Stefan Günther
University of Freiburg
4 shared publications - Wolfgang Sippl
Department of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany
4 shared publications
Latest Publications
- Open Access
The Nutraceutical Potential of Blackcurrant (Ribes nigrum) for Glycemic Control and Metabolic Health: Mechanistic and Translational Insights
Diabetes mellitus is a pervasive global health crisis, with type 2 diabetes (T2D) representing the majority of cases. While conventional pharmacological therapies exist, suboptimal efficacy, adverse effects, and inadequate glycemic control in a substantial proportion of patients highlight the need for complementary strategies. There is growing scientific and clinical interest in plant-based functional foods, including Ribes nigrum L. (blackcurrant), which is rich in bioactive phytochemicals such as anthocyanins, flavonols, and phenolic acids. This review evaluates the antidiabetic and metabolic regulatory potential of blackcurrant, focusing on its multi-target mechanisms of action. Available experimental evidence suggests that blackcurrants may influence glucose metabolism through several mechanisms, including inhibition of carbohydrate-digesting enzymes (α-amylase and α-glucosidase), modulation of intestinal glucose transporters (SGLT1 and GLUT2), and potential modulation of insulin sensitivity involving AMPK signaling and GLUT4 translocation. In addition, blackcurrant constituents may stimulate glucagon-like peptide-1 (GLP-1) secretion, modulate gut microbiota composition, and exert antioxidant and anti-inflammatory effects that counteract key drivers of insulin resistance and β-cell dysfunction. Supporting human studies indicate that blackcurrant consumption has been associated with attenuation of postprandial glycemic and insulinemic responses and modest improvements in cardiometabolic biomarkers, although findings remain limited by study size, duration, and formulation heterogeneity. Overall, Ribes nigrum represents a promising dietary adjunct for the prevention and management of T2D through multi-target metabolic regulation.
Open AccessThe Nutraceutical Potential of Blackcurrant (Ribes nigrum) for Glycemic Control and Metabolic Health: Mechanistic and Translational Insights
Diabetes mellitus is a pervasive global health crisis, with type 2 diabetes (T2D) representing the majority of cases. While conventional pharmacological therapies exist, suboptimal efficacy, adverse effects, and inadequate glycemic control in a substantial proportion of patients highlight the need for complementary strategies. There is growing scientific and clinical interest in plant-based functional foods, including Ribes nigrum L. (blackcurrant), which is rich in bioactive phytochemicals such as anthocyanins, flavonols, and phenolic acids. This review evaluates the antidiabetic and metabolic regulatory potential of blackcurrant, focusing on its multi-target mechanisms of action. Available experimental evidence suggests that blackcurrants may influence glucose metabolism through several mechanisms, including inhibition of carbohydrate-digesting enzymes (α-amylase and α-glucosidase), modulation of intestinal glucose transporters (SGLT1 and GLUT2), and potential modulation of insulin sensitivity involving AMPK signaling and GLUT4 translocation. In addition, blackcurrant constituents may stimulate glucagon-like peptide-1 (GLP-1) secretion, modulate gut microbiota composition, and exert antioxidant and anti-inflammatory effects that counteract key drivers of insulin resistance and β-cell dysfunction. Supporting human studies indicate that blackcurrant consumption has been associated with attenuation of postprandial glycemic and insulinemic responses and modest improvements in cardiometabolic biomarkers, although findings remain limited by study size, duration, and formulation heterogeneity. Overall, Ribes nigrum represents a promising dietary adjunct for the prevention and management of T2D through multi-target metabolic regulation.
- 10 May 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (5) , e02045
Natural Products in Gambeya lacourtiana (Sapotaceae): Identification, In Vitro Cytoxicity, and Deep Learning‐Based Pharmacokinetic Prediction
Cancer is a leading cause of death worldwide, and chemotherapy is facing challenges ranging from side effects, selectivity, and resistance. Molecules from nature are a prolific source of anticancer molecules. This study aimed to discover new anticancer molecules from Gambeya lacourtiana stem bark extract using in vitro assays. Complete assignment of the NMR data of 3, 5, 7, 3 ' , 5 ' ‐pentahydroxy‐4 ' ‐methoxyflavane or 4 ' ‐methoxyepigallocatechin ( 1 ) isolated from the stem bark of G. lacourtiana along with (‐)‐epicatechin ( 2 ), β ‐amyrin pentanoate ( 3 ), α ‐amyrin acetate ( 4 ), lupeol acetate ( 5 ), taraxerol ( 6 ), 28‐hydroxyl‐3 β ‐amyrin ( 7 ), euscaphic acid ( 8 ), betulinic acid ( 9 ), chondrillasterol ( 10 ), and 3‐ O ‐ β ‐D‐glucopyranosyl chondrillasterol ( 11 ) was achieved. Structures were elucidated by the interpretation of their NMR and spectrometric data in conjunction with literature data. In vitro cytotoxicity carried out on isolates toward CCRF‐CEM revealed only compound 1 to be moderately cytotoxic (IC 50 = 29.45 µg/mL). PASS analysis suggested that the isolated compounds had antineoplastic, antiproliferative, anti‐inflammatory, hepatoprotective, chemopreventive, membrane integrity agonist, mucomembranous protector, insulin promoter, fibrinolytic, and antioxidant effects. In addition, isolates were projected to treat hepatic disorders, leishmaniasis, wounds, proliferative diseases, capillary fragility, hypercholesterolemia, influenza, eczema, and leukemia. Predictions on its inhibition of testosterone 17 β ‐dehydrogenase (NADP+), a key enzyme involved in androgen metabolism, corroborate the use of this plant traditionally to solve reproductive health issues.
- 10 May 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (5) , e02045
Natural Products in Gambeya lacourtiana (Sapotaceae): Identification, In Vitro Cytoxicity, and Deep Learning‐Based Pharmacokinetic Prediction
Cancer is a leading cause of death worldwide, and chemotherapy is facing challenges ranging from side effects, selectivity, and resistance. Molecules from nature are a prolific source of anticancer molecules. This study aimed to discover new anticancer molecules from Gambeya lacourtiana stem bark extract using in vitro assays. Complete assignment of the NMR data of 3, 5, 7, 3 ' , 5 ' ‐pentahydroxy‐4 ' ‐methoxyflavane or 4 ' ‐methoxyepigallocatechin ( 1 ) isolated from the stem bark of G. lacourtiana along with (‐)‐epicatechin ( 2 ), β ‐amyrin pentanoate ( 3 ), α ‐amyrin acetate ( 4 ), lupeol acetate ( 5 ), taraxerol ( 6 ), 28‐hydroxyl‐3 β ‐amyrin ( 7 ), euscaphic acid ( 8 ), betulinic acid ( 9 ), chondrillasterol ( 10 ), and 3‐ O ‐ β ‐D‐glucopyranosyl chondrillasterol ( 11 ) was achieved. Structures were elucidated by the interpretation of their NMR and spectrometric data in conjunction with literature data. In vitro cytotoxicity carried out on isolates toward CCRF‐CEM revealed only compound 1 to be moderately cytotoxic (IC 50 = 29.45 µg/mL). PASS analysis suggested that the isolated compounds had antineoplastic, antiproliferative, anti‐inflammatory, hepatoprotective, chemopreventive, membrane integrity agonist, mucomembranous protector, insulin promoter, fibrinolytic, and antioxidant effects. In addition, isolates were projected to treat hepatic disorders, leishmaniasis, wounds, proliferative diseases, capillary fragility, hypercholesterolemia, influenza, eczema, and leukemia. Predictions on its inhibition of testosterone 17 β ‐dehydrogenase (NADP+), a key enzyme involved in androgen metabolism, corroborate the use of this plant traditionally to solve reproductive health issues.
- Open Access
- 9 May 2026
- Published by Elsevier in Applied Food Research
- Vol. 6 (2)
Technological innovations for enhancing phytonutrient content, stability, and bioavailability in foods
- 9 May 2026
- Published by Elsevier in Applied Food Research
- Vol. 6 (2)
Open AccessTechnological innovations for enhancing phytonutrient content, stability, and bioavailability in foods
- Open Access
- 17 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (D1) , D1336-D1344
African Natural Products Database (ANPDB): A resource for exploring the therapeutic potential of natural compounds from Africa
The African Natural Products Database (ANPDB) is a comprehensive repository currently encompassing over 11 000 natural compounds sourced from diverse species across the African continent. ANPDB integrates both experimental and predicted NMR and MS data to enhance compound annotation and facilitate dereplication, utilizing machine learning algorithms for spectral simulation and fragment prediction. The database offers a range of methods for compound structure search, including substructure matching, chemical similarity analysis, and property-based filtering, empowering users to efficiently explore chemical diversity. ANPDB also compiles detailed metadata on the traditional medicinal uses of source organisms, linking ethnobotanical knowledge with chemical and biological data. By consolidating information on biological sources, bioactivities, traditional applications, and bibliographic references (currently ranging from 1961 to 2024), ANPDB provides a robust platform for drug discovery, natural products research, and the exploration of Africa’s unique chemical and medicinal biodiversity. The database is open access, and the entire dataset and metadata are available for download and for computer-aided drug design endeavours. Link to the website: https://african-compounds.org
- 17 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (D1) , D1336-D1344
Open AccessAfrican Natural Products Database (ANPDB): A resource for exploring the therapeutic potential of natural compounds from Africa
The African Natural Products Database (ANPDB) is a comprehensive repository currently encompassing over 11 000 natural compounds sourced from diverse species across the African continent. ANPDB integrates both experimental and predicted NMR and MS data to enhance compound annotation and facilitate dereplication, utilizing machine learning algorithms for spectral simulation and fragment prediction. The database offers a range of methods for compound structure search, including substructure matching, chemical similarity analysis, and property-based filtering, empowering users to efficiently explore chemical diversity. ANPDB also compiles detailed metadata on the traditional medicinal uses of source organisms, linking ethnobotanical knowledge with chemical and biological data. By consolidating information on biological sources, bioactivities, traditional applications, and bibliographic references (currently ranging from 1961 to 2024), ANPDB provides a robust platform for drug discovery, natural products research, and the exploration of Africa’s unique chemical and medicinal biodiversity. The database is open access, and the entire dataset and metadata are available for download and for computer-aided drug design endeavours. Link to the website: https://african-compounds.org
- 24 October 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 22 (12) , e01035
Iboga‐Indole Alkaloids as Potential Plasmodial Inhibitors: Identification, Biosynthesis, and Molecular Docking Studies
A previously undescribed iboga‐indole alkaloid, voacamine A ( 1 ), and the known alkaloids, voacamine ( 2 ), voacorine ( 3 ), and voacangine ( 4 ) were isolated from the stem bark of Voacanga africana . The structures of the alkaloids were established by one‐ and two‐dimensional nuclear magnetic resonance analyses as well as by comparison with published data. The antiplasmodial activity of the alkaloids was assessed on a chloroquine‐sensitive 3D7 Plasmodium falciparum ( Pf3D7 ) strain, and the half‐maximal inhibitory concentration (IC 50 ) values were determined. Alkaloids 2 and 3 showed good in vitro antiplasmodial activity with IC 50 values of 5.734 ± 1.365 and 5.319 ± 2.206 µg/mL, respectively, at the concentration tested. A plausible biogenetic pathway of the bisindole alkaloids has been proposed. Protein‐ligand co‐folding was used to generate protein‐ligand complexes for the pfATP6 protein target and the isolated alkaloids. The stability of the modelled complexes was evaluated using molecular dynamics simulation. Scoring metrics of the generated complexes coupled to molecular mechanics generalized‐born solvation rescoring of the modelled ligand poses were employed to explain the antimalarial structure‐activity relationship for the investigated compounds. Alkaloids 2 and 3 can be considered as possible scaffolds for designing new antiplasmodial lead compounds.
- 24 October 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 22 (12) , e01035
Iboga‐Indole Alkaloids as Potential Plasmodial Inhibitors: Identification, Biosynthesis, and Molecular Docking Studies
A previously undescribed iboga‐indole alkaloid, voacamine A ( 1 ), and the known alkaloids, voacamine ( 2 ), voacorine ( 3 ), and voacangine ( 4 ) were isolated from the stem bark of Voacanga africana . The structures of the alkaloids were established by one‐ and two‐dimensional nuclear magnetic resonance analyses as well as by comparison with published data. The antiplasmodial activity of the alkaloids was assessed on a chloroquine‐sensitive 3D7 Plasmodium falciparum ( Pf3D7 ) strain, and the half‐maximal inhibitory concentration (IC 50 ) values were determined. Alkaloids 2 and 3 showed good in vitro antiplasmodial activity with IC 50 values of 5.734 ± 1.365 and 5.319 ± 2.206 µg/mL, respectively, at the concentration tested. A plausible biogenetic pathway of the bisindole alkaloids has been proposed. Protein‐ligand co‐folding was used to generate protein‐ligand complexes for the pfATP6 protein target and the isolated alkaloids. The stability of the modelled complexes was evaluated using molecular dynamics simulation. Scoring metrics of the generated complexes coupled to molecular mechanics generalized‐born solvation rescoring of the modelled ligand poses were employed to explain the antimalarial structure‐activity relationship for the investigated compounds. Alkaloids 2 and 3 can be considered as possible scaffolds for designing new antiplasmodial lead compounds.
- Open Access
- 16 October 2025
- Published by Open Exploration Publishing in Exploration of digital health technologies
- Vol. 3, 101166
Global innovative perspectives and trends on digital health and patient safety: highlights from the #DHPSP2024 networking event
Aim: This manuscript summarizes the key scientific and practical outcomes of the #DHPSP2024 digital networking event, focusing on emerging trends in digital health technologies, innovations in patient safety, and their implications for improving healthcare delivery. Methods: The #DHPSP2024 event was held from June 18 to 20, 2024, on X (formerly Twitter) and LinkedIn, connecting professionals and stakeholders in digital health and patient safety from different sectors. Data from posts on X and LinkedIn were analyzed for geographical distribution, engagement metrics (impressions, likes, shares), top hashtags, and frequently used terms. A qualitative analysis of the central themes and key online messaging discussions of the network event was also conducted. Results: On X, 2,329 posts by 179 participants from 38 countries generated over 231,000 impressions, with the most activity in Austria, China, and India. LinkedIn engagement included 3,475 likes, 217 comments, and 2,030 shares. Both platforms highlighted core themes such as digital health, patient safety, treatment quality, research on natural compounds, and interdisciplinary collaboration. Online messaging discussions emphasized technologies like telemedicine and artificial intelligence as critical tools for enhancing care delivery and patient safety. Participants also promoted special issues of scientific journals and explored collaborative research opportunities. Conclusions: The #DHPSP2024 event underscored the pivotal role of digital technologies in transforming healthcare, particularly in improving the quality and safety of interventions. The findings demonstrate how digital networking events, grounded in open innovation, foster global research communities, accelerate knowledge exchange, and support the integration of clinically relevant digital solutions. The strong engagement reflects growing interest in leveraging digital platforms to advance health outcomes and professional development. Overall, the event contributed to greater visibility of ongoing research, encouraged interdisciplinary cooperation, and may positively influence both the adoption of innovations in healthcare practice and the dissemination of scientific knowledge.
- 16 October 2025
- Published by Open Exploration Publishing in Exploration of digital health technologies
- Vol. 3, 101166
Open AccessGlobal innovative perspectives and trends on digital health and patient safety: highlights from the #DHPSP2024 networking event
Aim: This manuscript summarizes the key scientific and practical outcomes of the #DHPSP2024 digital networking event, focusing on emerging trends in digital health technologies, innovations in patient safety, and their implications for improving healthcare delivery. Methods: The #DHPSP2024 event was held from June 18 to 20, 2024, on X (formerly Twitter) and LinkedIn, connecting professionals and stakeholders in digital health and patient safety from different sectors. Data from posts on X and LinkedIn were analyzed for geographical distribution, engagement metrics (impressions, likes, shares), top hashtags, and frequently used terms. A qualitative analysis of the central themes and key online messaging discussions of the network event was also conducted. Results: On X, 2,329 posts by 179 participants from 38 countries generated over 231,000 impressions, with the most activity in Austria, China, and India. LinkedIn engagement included 3,475 likes, 217 comments, and 2,030 shares. Both platforms highlighted core themes such as digital health, patient safety, treatment quality, research on natural compounds, and interdisciplinary collaboration. Online messaging discussions emphasized technologies like telemedicine and artificial intelligence as critical tools for enhancing care delivery and patient safety. Participants also promoted special issues of scientific journals and explored collaborative research opportunities. Conclusions: The #DHPSP2024 event underscored the pivotal role of digital technologies in transforming healthcare, particularly in improving the quality and safety of interventions. The findings demonstrate how digital networking events, grounded in open innovation, foster global research communities, accelerate knowledge exchange, and support the integration of clinically relevant digital solutions. The strong engagement reflects growing interest in leveraging digital platforms to advance health outcomes and professional development. Overall, the event contributed to greater visibility of ongoing research, encouraged interdisciplinary cooperation, and may positively influence both the adoption of innovations in healthcare practice and the dissemination of scientific knowledge.
- 16 April 2025
- Published by Wiley in Chemistry & Biodiversity
- p. e202403352
Natural Products in Cyperus Species (Cyperaceae): Phytochemistry, Pharmacological Activities, and Biosynthesis
The review provides an update on the traditional uses, geographical distribution, pharmacological activities, biosynthesis, and mechanisms of action of potent natural products derived from Cyperus species. Cyperus species are widely distributed in the tropical and subtropical regions across the globe. Cyperus is the second‐largest genus in this family with about 950 species. Since 1964, a total of about 403 natural products have been isolated from 43 Cyperus species, including terpenoids (51.61%), flavonoids (17.37%), stilbenoids (6.45%), quinones (5.71%), aromatics (7.69%), coumarins (5.21%), and other compounds (5.96%). The isolated compounds displayed anticancer, antiviral, antidiabetic, antimicrobial, antidepressant, and other activities. Terpenoids and flavonoids are the most abundant class of natural products that have been isolated from Cyperus species. The biosynthesis of some terpenoids and flavonoids has been provided in the paper. Natural products isolated from Cyperus species have demonstrated interesting in vitro activities that warrant further scientific investigations.
- 16 April 2025
- Published by Wiley in Chemistry & Biodiversity
- p. e202403352
Natural Products in Cyperus Species (Cyperaceae): Phytochemistry, Pharmacological Activities, and Biosynthesis
The review provides an update on the traditional uses, geographical distribution, pharmacological activities, biosynthesis, and mechanisms of action of potent natural products derived from Cyperus species. Cyperus species are widely distributed in the tropical and subtropical regions across the globe. Cyperus is the second‐largest genus in this family with about 950 species. Since 1964, a total of about 403 natural products have been isolated from 43 Cyperus species, including terpenoids (51.61%), flavonoids (17.37%), stilbenoids (6.45%), quinones (5.71%), aromatics (7.69%), coumarins (5.21%), and other compounds (5.96%). The isolated compounds displayed anticancer, antiviral, antidiabetic, antimicrobial, antidepressant, and other activities. Terpenoids and flavonoids are the most abundant class of natural products that have been isolated from Cyperus species. The biosynthesis of some terpenoids and flavonoids has been provided in the paper. Natural products isolated from Cyperus species have demonstrated interesting in vitro activities that warrant further scientific investigations.
- Open Access
- 29 March 2025
- Published by Elsevier in Biotechnology Advances
- Vol. 82, 108568
Application of curcuminoids in inflammatory, neurodegenerative and aging conditions - Pharmacological potential and bioengineering approaches to improve efficiency
- 29 March 2025
- Published by Elsevier in Biotechnology Advances
- Vol. 82, 108568
Open AccessApplication of curcuminoids in inflammatory, neurodegenerative and aging conditions - Pharmacological potential and bioengineering approaches to improve efficiency
- Open Access
- 5 November 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (D1) , D724-D729
StreptomeDB 4.0: a comprehensive database of streptomycetes natural products enriched with protein interactions and interactive spectral visualization
Streptomycetes remain an important bacterial source of natural products (NPs) with significant therapeutic promise, particularly in the fight against antimicrobial resistance. Herein, we present StreptomeDB 4.0, a substantial update of the database that includes expanded content and several new features. Currently, StreptomeDB 4.0 contains over 8500 NPs originating from ∼3900 streptomycetes, manually annotated from ∼7600 PubMed-indexed peer-reviewed articles. The database was enhanced by two in-house developments: (i) automated literature-mined NP–protein relationships (hyperlinked to the CPRiL web server) and (ii) pharmacophore-based NP–protein interactions (predicted with the ePharmaLib dataset). Moreover, genome mining was supplemented through hyperlinks to the widely used antiSMASH database. To facilitate NP structural dereplication, interactive visualization tools were implemented, namely the JSpecView applet and plotly.js charting library for predicted nuclear magnetic resonance and mass spectrometry spectral data, respectively. Furthermore, both the backend database and the frontend web interface were redesigned, and several software packages, including PostgreSQL and Django, were updated to the latest versions. Overall, this comprehensive database serves as a vital resource for researchers seeking to delve into the metabolic intricacies of streptomycetes and discover novel therapeutics, notably antimicrobial agents. StreptomeDB is publicly accessible at https://www.pharmbioinf.uni-freiburg.de/streptomedb.
- 5 November 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (D1) , D724-D729
Open AccessStreptomeDB 4.0: a comprehensive database of streptomycetes natural products enriched with protein interactions and interactive spectral visualization
Streptomycetes remain an important bacterial source of natural products (NPs) with significant therapeutic promise, particularly in the fight against antimicrobial resistance. Herein, we present StreptomeDB 4.0, a substantial update of the database that includes expanded content and several new features. Currently, StreptomeDB 4.0 contains over 8500 NPs originating from ∼3900 streptomycetes, manually annotated from ∼7600 PubMed-indexed peer-reviewed articles. The database was enhanced by two in-house developments: (i) automated literature-mined NP–protein relationships (hyperlinked to the CPRiL web server) and (ii) pharmacophore-based NP–protein interactions (predicted with the ePharmaLib dataset). Moreover, genome mining was supplemented through hyperlinks to the widely used antiSMASH database. To facilitate NP structural dereplication, interactive visualization tools were implemented, namely the JSpecView applet and plotly.js charting library for predicted nuclear magnetic resonance and mass spectrometry spectral data, respectively. Furthermore, both the backend database and the frontend web interface were redesigned, and several software packages, including PostgreSQL and Django, were updated to the latest versions. Overall, this comprehensive database serves as a vital resource for researchers seeking to delve into the metabolic intricacies of streptomycetes and discover novel therapeutics, notably antimicrobial agents. StreptomeDB is publicly accessible at https://www.pharmbioinf.uni-freiburg.de/streptomedb.
- 31 March 2024
- Published by Springer Nature
- p. 735-774
Bioactive Compounds and Biological Activities of Cyperus rotundus L. (Cyperaceae)
- 31 March 2024
- Published by Springer Nature
- p. 735-774
Bioactive Compounds and Biological Activities of Cyperus rotundus L. (Cyperaceae)